147 related articles for article (PubMed ID: 25181014)
1. Impact of educational programme regarding chelation therapy on the quality of life for B-thalassemia major children.
Abu Samra O; Auda W; Kamhawy H; Al-Tonbary Y
Hematology; 2015 Jun; 20(5):297-303. PubMed ID: 25181014
[TBL] [Abstract][Full Text] [Related]
2. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience.
Abdelrazik N
Hematology; 2007 Dec; 12(6):577-85. PubMed ID: 17852442
[TBL] [Abstract][Full Text] [Related]
3. Pilot study on the "quality of life" as reflected by psychosocial adjustment of children with thalassemia major undergoing iron-chelating treatment in western Taiwan.
Kuo HT; Tsai MY; Peng CT; Wu KH
Hemoglobin; 2006; 30(2):291-9. PubMed ID: 16798654
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life Outcomes in a Pediatric Thalassemia Population in Egypt.
Adam S; Afifi H; Thomas M; Magdy P; El-Kamah G
Hemoglobin; 2017 Jan; 41(1):16-20. PubMed ID: 28440111
[TBL] [Abstract][Full Text] [Related]
5. Combined chelation therapy with deferoxamine and deferiprone in β-thalassemia major: compliance and opinions of young thalassemic patients.
Hatzipantelis ES; Karasmanis K; Perifanis V; Vlachaki E; Tziomalos K; Economou M
Hemoglobin; 2014; 38(2):111-4. PubMed ID: 24351163
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in Thai thalassemic children treated with iron chelation.
Torcharus K; Pankaew T
Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):951-9. PubMed ID: 22299478
[TBL] [Abstract][Full Text] [Related]
7. Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).
Mokhtar GM; Gadallah M; El Sherif NH; Ali HT
Pediatr Hematol Oncol; 2013 Mar; 30(2):93-103. PubMed ID: 23301991
[TBL] [Abstract][Full Text] [Related]
8. Thalassemia Minor and Major: Current Management.
Choudhry VP
Indian J Pediatr; 2017 Aug; 84(8):607-611. PubMed ID: 28435994
[TBL] [Abstract][Full Text] [Related]
9. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
Tanphaichitr A; Kusuwan T; Limviriyakul S; Atipas S; Pooliam J; Sangpraypan T; Tanphaichitr VS; Viprakasit V
Hemoglobin; 2014; 38(5):345-50. PubMed ID: 25051423
[TBL] [Abstract][Full Text] [Related]
10. Unbalanced bone turnover in children with beta-thalassemia.
Salama OS; Al-Tonbary YA; Shahin RA; Eldeen OA
Hematology; 2006 Jun; 11(3):197-202. PubMed ID: 17325962
[TBL] [Abstract][Full Text] [Related]
11. [Beta-thalassemia major in children and adolescents in Denmark].
Jung A; Main KM; Scheibel E; Peitersen B; Clausen N; Erichsen G; Schmiegelow K; Illum N
Ugeskr Laeger; 2002 Dec; 164(49):5803-6. PubMed ID: 12523224
[TBL] [Abstract][Full Text] [Related]
12. Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
El-Beshlawy A; Manz C; Naja M; Eltagui M; Tarabishi C; Youssry I; Sobh H; Hamdy M; Sharaf I; Mostafa A; Shaker O; Hoffbrand AV; Taher A
Ann Hematol; 2008 Jul; 87(7):545-50. PubMed ID: 18351337
[TBL] [Abstract][Full Text] [Related]
13. Quality of life among children with beta-thalassemia major treated in Western Saudi Arabia.
Ayoub MD; Radi SA; Azab AM; Abulaban AA; Balkhoyor AH; Bedair SW; Aljaouni SK; Kari JA
Saudi Med J; 2013 Dec; 34(12):1281-6. PubMed ID: 24343469
[TBL] [Abstract][Full Text] [Related]
14. Cultural preferences and limited public resources influence the spectrum of thalassemia in Egypt.
Adly AA; Ebeid FS
J Pediatr Hematol Oncol; 2015 May; 37(4):281-4. PubMed ID: 25811748
[TBL] [Abstract][Full Text] [Related]
15. A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with β-thalassemia major.
Elalfy MS; Massoud W; Elsherif NH; Labib JH; Elalfy OM; Elaasar S; von Mackensen S
Pediatr Blood Cancer; 2012 Jun; 58(6):910-5. PubMed ID: 22232075
[TBL] [Abstract][Full Text] [Related]
16. Thalassemia major is a major risk factor for pediatric melioidosis in Kota Kinabalu, Sabah, Malaysia.
Fong SM; Wong KJ; Fukushima M; Yeo TW
Clin Infect Dis; 2015 Jun; 60(12):1802-7. PubMed ID: 25767257
[TBL] [Abstract][Full Text] [Related]
17. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
[TBL] [Abstract][Full Text] [Related]
18. Thalassemia Major: how do we improve quality of life?
Dhirar N; Khandekar J; Bachani D; Mahto D
Springerplus; 2016; 5(1):1895. PubMed ID: 27843752
[TBL] [Abstract][Full Text] [Related]
19. Growth and sexual maturation in children with thalassemia major.
Yesilipek MA; Bircan I; Oygür N; Ertug H; Yegin O; Güven AG
Haematologica; 1993; 78(1):30-3. PubMed ID: 8491419
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the children with beta-thalassemia in terms of their self-concept, behavioral, and parental attitudes.
Yalçn SS; Durmuşoğlu-Sendoğdu M; Gümrük F; Unal S; Karg E; Tuğrul B
J Pediatr Hematol Oncol; 2007 Aug; 29(8):523-8. PubMed ID: 17762492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
